Welcome to LookChem.com Sign In|Join Free

CAS

  • or

172336-33-3

Post Buying Request

172336-33-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Ethyl (3S,5R,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl ]-3,5-dihydroxy-6-heptenoate

    Cas No: 172336-33-3

  • No Data

  • No Data

  • No Data

  • Chemlyte Solutions
  • Contact Supplier

172336-33-3 Usage

General Description

[R-(R*,S*)]-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid ethyl ester is a complex chemical compound that is commonly used in pharmaceutical research. It is an ethyl ester derivative of a type of heptenoic acid, which is a type of unsaturated fatty acid. The compound contains a quinolinyl ring, a cyclopropyl group, and a fluorophenyl group, all of which contribute to its unique structure and potential pharmaceutical properties. [R-(R*,S*)]-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid ethyl ester may have applications in the development of new drugs for various conditions, and its structure makes it an interesting target for further research and exploration in the field of medicinal chemistry.

Check Digit Verification of cas no

The CAS Registry Mumber 172336-33-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,2,3,3 and 6 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 172336-33:
(8*1)+(7*7)+(6*2)+(5*3)+(4*3)+(3*6)+(2*3)+(1*3)=123
123 % 10 = 3
So 172336-33-3 is a valid CAS Registry Number.

172336-33-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl (3S,5R,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl ]-3,5-dihydroxy-6-heptenoate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:172336-33-3 SDS

172336-33-3Relevant articles and documents

METHOD FOR PRODUCING PITAVASTATIN CALCIUM

-

Paragraph 0228; 0229; 0230, (2018/08/25)

Production of pitavastatin calcium safely on an industrial scale with a high yield and high selectivity at low cost. A method of producing pitavastatin calcium including step (i) for acetalizing a compound represented by the formula (1) to give a compound represented by the formula (3), step (ii) for reacting a compound represented by the formula (3) with an acid to give a compound represented by the formula (4), and step (iii) for hydrolyzing a compound represented by the formula (4) and reacting same with a calcium compound.

A pitavastatin calcium bulk drug intermediate preparation method

-

, (2017/08/25)

The invention discloses a preparing method for a pitavastatin calcium bulk drug intermediate. The intermediate is (+/-) E-6-[2- cyclopropyl-4-(4-fluorophenyl)-quinoline-3-phenyl vinyl]-4-hydroxy-3,4,5,6-tetralin-valerolactone. The method comprises the ste

Process for producing (3R,5S)-(E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-quinolin- 3-yl]-3, 5-dihydroxyhept-6-enic acid esters

-

Page 14-15, (2010/02/05)

A process for producing a compound represented by the following formula (IV): (wherein R denotes a hydrogen atom, an alkyl group, or an aryl group), comprising reducing a compound selected from the group consisting of: a compound represented by the following formula (I): (wherein R is as defined in the formula); a compound represented by the following formula (II): (wherein R is as defined in the formula); and a compound represented by the following formula (III): (wherein R is as defined in the formula), by reacting the compound with a cell of a microorganism and/or a cell preparation thereof capable of stereo-selectively reducing a keto group.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 172336-33-3